Background
==========

T helper 17 (Th17) cells are a subset of CD4+ Th cells characterized by the production of high levels of interleukin (IL)-17A (also known commonly as IL-17) \[[@b1-medscimonit-23-535]\]. Besides IL-17A, Th17 cells secret other pro-inflammatory cytokines, such as IL-21, IL-22, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor. Differentiation of naïve CD4+ T cells into Th17 cells requires the coordinated activities of several microenvironmental cues. The cytokines IL-6 and TGF-β induce Th17 cell differentiation by activating retinoid-related orphan receptor (ROR)-γt, a master transcription factor required for the generation of Th17 cells \[[@b2-medscimonit-23-535]\]. IL-1β and IL-23 cytokines can promote and stabilize previously differentiated Th17 cells \[[@b3-medscimonit-23-535]\]. Accumulating evidence suggests that Th17 cells are major drivers of inflammation and have been implicated in the pathogenesis of multiple autoimmune and immune-mediated inflammatory diseases, including rheumatoid arthritis, multiple sclerosis, asthma, and Behçet's disease \[[@b4-medscimonit-23-535]--[@b8-medscimonit-23-535]\]. Given the important role of IL-17 cells in regulating autoimmunity and inflammation, elaborating the factors and processes that govern the differentiation of Th17 cells are necessary for developing Th17-targeted therapies.

Vitamin D is an important regulator of the immune system. Almost every immune cell type has been found to express vitamin D receptor (VDR) and/or the enzyme CYP27B1 that is required for the generation of the bioactive form of vitamin D, 1,25(OH)~2~D~3~ (also known as calcitriol) \[[@b9-medscimonit-23-535]\]. The action of 1,25(OH)~2~D~3~ is based on its binding to VDR, which is a ligand-dependent transcription factor, belonging to the steroid receptor superfamily. Upon ligand binding, VDR undergoes heterodimerization with the retinoid X receptor (RXR) and binds to hormone response elements on DNA, resulting in expression or transrepression of specific gene products \[[@b10-medscimonit-23-535]\]. Both *in vitro* and *in vivo* studies have found that 1,25(OH)~2~D~3~ treatment inhibits T cell commitment to the Th17 lineage as well as Th17 production of IL-17A. 1,25(OH)~2~D~3~ directly inhibits Th17 cell differentiation through the VDR signal in CD4+ T cells, independent of the IL-2, IL-10, and STAT1 signals \[[@b11-medscimonit-23-535]\]. In addition, 1,25(OH)~2~D~3~ suppresses cytokines in Th17 cells by inducing the C/EBP homologous protein (CHOP), a molecule involved in endoplasmic reticulum stress and translational inhibition \[[@b12-medscimonit-23-535]\]. Furthermore, 1,25(OH)~2~D~3~ inhibits production of IL-17A by blocking nuclear factor for activated T cells (NFAT), recruitment of histone deacetylase (HDAC), sequestration of Runt-related transcription factor 1 (Runx1), and induction of forkhead box P3 (Foxp3), a transcription factor associating with NFAT and Runx1 for transcriptional repression \[[@b13-medscimonit-23-535]\]. Although previous studies have obtained some encouraging evidence, our understanding of the mechanisms by which 1,25(OH)~2~D~3~ regulates Th17 differentiation remains limited.

MicroRNAs (miRNAs) are endogenous, small, non-coding RNAs approximately 22 nucleotides (nt) in length that are highly conserved across various species of eukaryotes. miRNAs posttranscriptionally repress gene expression by binding to complimentary sequences in the 3′ untranslated region (UTR) of target messenger RNA (mRNA) \[[@b14-medscimonit-23-535]\]. miRNAs are vital for controlling many processes within the immune system including the development and differentiation of lymphocytes, secretion of cytokines and chemokines, antibody switching, and regulation of immune tolerance \[[@b15-medscimonit-23-535]\]. Recently, several miRNAs have been implicated in Th17 cell differentiation. miR-155 promotes Th17 cell differentiation and IL-17A production by targeting suppressor of cytokine signaling 1 (SOCS-1), which is a molecule responsible for the negative regulation of the JAK-STAT pathway \[[@b16-medscimonit-23-535],[@b17-medscimonit-23-535]\] and suppressing the inhibitory effects of the DNA-binding protein Jarid2 \[[@b18-medscimonit-23-535]\]. miR-155-deficient mice show a defect in Th17 differentiation and strong resistance to experimental autoimmune encephalomyelitis (EAE), an experimental animal model for central nervous system demyelinating disease \[[@b18-medscimonit-23-535],[@b19-medscimonit-23-535]\]. miR-20b expression is down-regulated in Th17 cells during mouse EAE, and over-expression of miR-20b inhibits Th17 differentiation and ameliorates EAE by targeting ROR-γt and STAT3 \[[@b20-medscimonit-23-535]\]. In addition, miR-21, miR-181a, miR-210, and miR-301a are found to be involved in the development of Th17 cells \[[@b21-medscimonit-23-535]--[@b25-medscimonit-23-535]\].

Since both miRNAs and 1,25(OH)~2~D~3~ are crucial regulators of Th17 differentiation, it is of great interest to investigate their interaction in regulating Th17 differentiation. In the present study, we aim to evaluate the expression of several candidate miRNAs during Th17 differentiation and the effects of 1,25(OH)~2~D~3~ on Th17 differentiation and miRNA expression.

Material and Methods
====================

Peripheral blood mononuclear cells (PBMC) isolation
---------------------------------------------------

Human peripheral blood was obtained by venipuncture from 3 young healthy subjects (LZB, KY, and JFJ) and was collected into K2-ethylene diamine tetraacetic acid (K2-EDTA) vacutainer tubes (Shenzhen Medrey Medical Technology, China). Whole blood (4 mL) was mixed with 4 mL of phosphate-buffered saline and layered gently on 4 mL of lymphocyte separation medium (Dakewe Biotech Company, China) in a 15-mL centrifugate tube. PBMC were separated by using density centrifugation in a 25-min centrifugation step at 2500 rpm at room temperature. The mononuclear layer was collected from the interface of the blood plasma and the separation medium. After separation, PBMC were washed and cultivated at a density of 1.0×10^6^ cells/mL in RPMI 1640 (KeyGEN Biotech, China) containing 10% fetal bovine serum, L-glutamine, NaHCO~3~, penicillin, and streptomycin. Cells were incubated in a humidified atmosphere (37°C and 5% CO~2~).

Th17 cell generation
--------------------

To generate Th17 cells in PBMCs, anti-CD3 mAb (0.5 ng/L; BioLegend, USA), anti-CD28 mAb (0.5 ng/L; BioLegend, USA), recombinant human IL-1β (rhIL-1β; 100 ng/mL), rhIL-23 (100 ng/mL), rhIL-6 (100 ng/mL), and rhTGF-β1 (25 ng/mL) (all cytokines from PeproTech, USA) were added to the medium on day 0. When 1,25(OH)~2~D~3~ (Selleck Chemicals, USA) was used to treat the cells, a final concentration of 100 nM was employed according to the results of our pre-experiments (not shown). After 72 hours of culture, supernatants were collected, and IL-17A production in culture supernatants was analyzed by enzyme-linked immunosorbent assay (ELISA) (Dakewe Biotech Company, China) according to the manufacturer's instructions.

Quantitative PCR (qPCR)
-----------------------

After 72 hours of culture, total RNA containing small-size RNA was isolated from PBMCs using the miRCURY^TM^ RNA Isolation Kit (Exiqon, Denmark). The concentration of RNA was quantified using the NanoDrop 2000 spectrophotometer (Thermo, USA). First strand cDNA synthesis of miRNA was performed with the Mir-X miRNA First-Strand Synthesis Kit (Clontech, Japan). For generating cDNA, 5 μL of 2× mRQ buffer, 1.25 μL of mRQ enzyme, and 3.75 μL of RNA were used, for a total volume of 10 μL. The synthesis reaction was carried out at 37°C for 60 min, followed by 85°C for 5 min. cDNA was diluted with 90 μL of ddH~2~O to bring the total volume to 100 μL after reaction. For miRNA quantification, qPCR analysis was performed using the miR-X miRNA qRT-PCR SYBR Kit (Clontech, Japan) and the CFX96 qPCR system (BioRad, USA). The delta-delta C~t~ method was used to determine the expression of hsa-miR-20b, hsa-miR-21, hsa-miR-155, hsa-miR-181a, hsa-miR-210, and hsa-miR-301a normalized against that of U6 snRNA. The 3′ primer for qPCR was the mRQ 3′ primer supplied with the kit, whereas the 5′ primers for miRNAs were designed and synthesized by Takara Biotechnology (Dalian) ([Table 1](#t1-medscimonit-23-535){ref-type="table"}). The forward and reverse primers of U6 were provided with the kit. Reactions were incubated at 95°C for 10 seconds, followed by 40 cycles at 95°C for 5 seconds and 60°C for 20 seconds. Each sample was run in duplicate for analysis. At the end of the PCR cycles, melting curve analysis was performed to ensure the specificity of PCR products. Amplicons were also analyzed by agarose gel electrophoresis and visualized with ethidium bromide under UV transillumination to validate the specific generation of the expected PCR.

Statistical analysis
--------------------

Data are presented as median with interquartile range (IRQ) and were analyzed by nonparametric statistics with Stata version 11.0. A *P* value of \<0.05 was considered significant.

Results
=======

1,25(OH)~2~D~3~ suppressed *in vitro* differentiation of Th17 cells
-------------------------------------------------------------------

To generate Th17 cells, we isolated PBMC from healthy donors and activated them *in vitro* with anti-CD3 and anti-CD28 antibodies in the presence of polarizing cytokines IL-23, IL-1β, TGF-β1, and IL-6. After 72 hours of culture, we collected the culture medium and assessed IL-17A production by ELISA. As shown in [Figure 1](#f1-medscimonit-23-535){ref-type="fig"}, IL-17A was undetectable when cells received no stimulation, whereas a high level of IL-17A was detected under Th17-polarizing conditions (median \[IRQ\], 2535.4 \[2153.3\] pg/mL, *P*\<0.05) ([Figure 1](#f1-medscimonit-23-535){ref-type="fig"}), indicating a substantial increase in the number of IL-17A-expressing T cells. We tested 1,25(OH)~2~D~3~ for its capacity to inhibit Th17 differentiation by adding 1,25(OH)~2~D~3~ to the medium at a final concentration of 100 nM. After 72 hours of culture, IL-17A production was significantly decreased by 1,25(OH)~2~D~3~ under Th17-polarizing conditions (median \[IRQ\], 745.7 \[473.5\] pg/mL *vs.* 2535.4 \[2153.3\] pg/mL, *P*\<0.05) ([Figure 1](#f1-medscimonit-23-535){ref-type="fig"}).

Detection of miRNA expression by qPCR
-------------------------------------

The expression of miRNAs hsa-miR-20b, hsa-miR-21, hsa-miR-155, hsa-miR-181a, hsa-miR-210, and hsa-miR-301a was found to be changed under Th17-polarizing conditions. Of these miRNAs, hsa-miR-155 was significantly up-regulated (median fold change: 3.61, *P*\<0.05), whereas hsa-miR-20b, hsa-miR-21, hsa-miR-181a, hsa-miR-210, and hsa-miR-301a were significantly down-regulated (median fold change: 0.44, 0.37, 0.18, 0.15, and 0.26, respectively; *P*\<0.05) ([Table 2](#t2-medscimonit-23-535){ref-type="table"}, [Figure 2](#f2-medscimonit-23-535){ref-type="fig"}). Although 1,25(OH)~2~D~3~ significantly suppressed human Th17 differentiation, there was no change of miRNA expression after 1,25(OH)~2~D~3~ treatment ([Table 2](#t2-medscimonit-23-535){ref-type="table"}, [Figure 2](#f2-medscimonit-23-535){ref-type="fig"}). Melting curve analysis and agarose gel electrophoresis of qPCR products confirmed that the amplicons were specific (not shown).

Discussion
==========

The main findings of the present study are as follows: (1) we observed increased expression of hsa-miR-155 and decreased expression of hsa-miR-20b, hsa-miR-21, hsa-miR-181a, hsa-miR-210, and hsa-miR-301a during human Th17 differentiation; and (2) 1,25(OH)~2~D~3~ significantly suppressed human Th17 differentiation, but did not affect miRNA expression during this process. As far as we know, we provide the first evidence that 1,25(OH)~2~D~3~ suppresses human Th17 differentiation without influencing miRNA expression.

The classical function of 1,25(OH)~2~D~3~ is to maintain calcium-phosphate homeostasis and skeletal function. However, its role in modulation of immune responses has received considerable attention. Several previous studies have found that 1,25(OH)~2~D~3~ has the capacity to inhibit Th17 differentiation. The study by Ikeda et al. demonstrated that 1,25(OH)~2~D~3~ significantly inhibited Th17 differentiation by down-regulating the mRNA expression levels of RORC and aryl hydrocarbon receptor \[[@b26-medscimonit-23-535]\]. In addition, the inhibitory effect of 1,25(OH)~2~D~3~ on Th17 differentiation was found to be via the VDR signal in CD4+ T cells, but independent of IL-2, IL-10, and STAT1 signals \[[@b11-medscimonit-23-535]\]. Furthermore, it was shown that 1,25(OH)~2~D~3~ suppressed Th17 differentiation by blocking NFAT, recruitment of HDAC, sequestration of Runx1, and inducing CHOP and Foxp3 \[[@b12-medscimonit-23-535],[@b13-medscimonit-23-535]\]. Recently, Nanduri et al. reported that 1,25(OH)~2~D~3~ repressed Th17-specific genes by the Smad pathway and extracellular signal-regulated kinase activation \[[@b27-medscimonit-23-535]\]. Despite of these findings, our understanding of the mechanisms whereby 1,25(OH)~2~D~3~ regulates Th17 differentiation remains limited.

miRNAs represent a large family of about 22 nt long, noncoding, single-stranded RNA molecules. In mammals, miRNAs predominantly regulate gene expression by induction of mRNA degradation, and they play an important role in a variety of physiological and pathological processes. An involvement in the regulation of Th17 differentiation has recently been proposed for several miRNAs, including miR-20b, miR-21, miR-155, miR-181a, miR-210, and miR-301a \[[@b20-medscimonit-23-535]--[@b25-medscimonit-23-535]\]. Given that both 1,25(OH)~2~D~3~ and miRNAs are important regulators of Th17 differentiation, it is necessary to evaluate whether 1,25(OH)~2~D~3~ affects miRNA expression when exerting its inhibitory effects on Th17 differentiation.

In this study, we focused on six candidate miRNAs, including miR-20b, miR-21, miR-155, miR-181a, miR-210,and miR-301a, based on existing evidence from previous studies showing their relation with Th17 differentiation, rather than performing miRNA microarray analysis to identify candidates, because the former method was more efficient and targeted. In addition, we did not identify candidate miRNAs using in silico analysis because this method was relatively unreliable. The change of miRNA expression during Th17 differentiation was evaluated using qPCR. In agreement with the results from previous studies, all six miRNAs were found to be significantly dysregulated in the development of Th17 cells, with five down-regulated (hsa-miR-20b, hsa-miR-21, hsa-miR-181a, hsa-miR-210, and hsa-miR-301a) and one up-regulated (hsa-miR-155). It was noteworthy that most evidence on expression of miRNAs during Th17 differentiation to date has been derived from results using animal cell cultures \[[@b20-medscimonit-23-535]--[@b23-medscimonit-23-535],[@b25-medscimonit-23-535]\], whereas we evaluated these miRNAs using human cell cultures, which could provide more valuable evidence. In addition, most previous studies concentrated on a single miRNA, but we evaluated several miRNAs simultaneously in this study, which would provide more detailed information on change of miRNA expression during Th17 cell development.

We evaluated the effects of 1,25(OH)~2~D~3~ on Th17 differentiation and miRNA expression. 1,25(OH)~2~D~3~ significantly suppressed Th17 differentiation, but did not affect miRNA expression during this process, suggesting that 1,25(OH)~2~D~3~-mediated Th17 cell suppression was not dependent on regulation of miRNA expression. We noticed that our results were distinct from those on endothelial tissues and cancer cells, which showed that vitamin D regulated miRNA expression and was involved in miRNA-directed posttranscriptional mechanisms \[[@b28-medscimonit-23-535],[@b29-medscimonit-23-535]\]. The study by Zitman-Gal et al. found that miR-20b expression was up-regulated by 1,25(OH)~2~D~3~ in endothelial cells exposed to a diabetic-like environment \[[@b28-medscimonit-23-535]\], and this change of expression played a role in the modulation of endothelial function. Another study by Sheane et al. demonstrated that vitamin D deficiency up-regulated miR-21 expression in the aorta, which contributed to the development of atherosclerosis \[[@b29-medscimonit-23-535]\]. In addition, cancer studies also showed that 1,25(OH)~2~D~3~ regulated the expression of a subset of miRNAs with potential regulatory functions in cancer pathways \[[@b30-medscimonit-23-535]--[@b32-medscimonit-23-535]\]. However, we did not find miRNA involvement in 1,25(OH)~2~D~3~-mediated suppression of Th17 differentiation in this study. Our results indicate that 1,25(OH)~2~D~3~ exerts its functions via distinct mechanisms across different cell types, not through miRNAs in Th17 cells.

Conclusions
===========

Our study showed that six miRNAs were dysregulated during human Th17 differentiation, with one significantly up-regulated (hsa-miR-155) and five significantly down-regulated (hsa-miR-20b, hsa-miR-21, hsa-miR-181a, hsa-miR-210, and hsa-miR-301a). 1,25(OH)~2~D~3~ did not affect the expression of these miRNAs when suppressing Th17 differentiation.
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![Suppression of IL-17A expression by 1,25(OH)~2~D~3~. No stimulation: peripheral blood mononuclear cells (PBMC) were cultured for 72 hours without any stimulation. Th17: PBMC were cultured for 72 hours under Th17-polarizing conditions. Th17 + Vit D: PBMC were cultured for 72 hours under Th17-polarizing conditions, and 1,25(OH)~2~D~3~ was added to the medium at a final concentration of 100 nM on day 0. Data are presented as median with interquartile range. *P*\<0.05.](medscimonit-23-535-g001){#f1-medscimonit-23-535}

![Detection of miRNA expression by real time PCR. No stimulation: peripheral blood mononuclear cells (PBMC) were cultured for 72 hours without any stimulation. Th17: PBMC were cultured for 72 hours under Th17-polarizing conditions. Th17 + Vit D: PBMC were cultured for 72 hours under Th17-polarizing conditions, and 1,25(OH)~2~D~3~ was added to the medium at a final concentration of 100 nM on day 0. Data are presented as median with interquartile range. *P*\<0.05, ^Δ^ *P*\>0.05.](medscimonit-23-535-g002){#f2-medscimonit-23-535}

###### 

qPCR primers for miRNAs.

  miRNA          Accession number in miR base   miRNA sequence            5′ primer
  -------------- ------------------------------ ------------------------- -------------------------
  hsa-miR-20b    MIMAT0001413                   CAAAGUGCUCAUAGUGCAGGUAG   GGCTCATAGTGCAGGTAGAAA
  hsa-miR-21     MIMAT0000076                   UAGCUUAUCAGACUGAUGUUGA    TCGTGGCAGACTGATGTTGAAAA
  hsa-miR-155    MIMAT0000646                   UUAAUGCUAAUCGUGAUAGGGGU   CAATGCTAATCGTGATAGGGGT
  hsa-miR-181a   MIMAT0000256                   AACAUUCAACGCUGUCGGUGAGU   CCTTCGCTGTCGGTGAGTAAA
  hsa-miR-210    MIMAT0026475                   AGCCCCUGCCCACCGCACACUG    CGTTCCCACCGCACACTGAAA
  hsa-miR-301a   MIMAT0022696                   GCUCUGACUUUAUUGCACUACU    GCTCTGACTTTATTGCACTACT

###### 

Fold change of miRNA expression.

  miRNA          Fold change                                                             
  -------------- ------------- --------------------------------------------------------- --------------------------------------------------------
  hsa-miR-155    1             3.61[\*](#tfn1-medscimonit-23-535){ref-type="table-fn"}   2.04[Δ](#tfn2-medscimonit-23-535){ref-type="table-fn"}
  hsa-miR-20b    1             0.44[\*](#tfn1-medscimonit-23-535){ref-type="table-fn"}   0.34[Δ](#tfn2-medscimonit-23-535){ref-type="table-fn"}
  hsa-miR-21     1             0.37[\*](#tfn1-medscimonit-23-535){ref-type="table-fn"}   0.70[Δ](#tfn2-medscimonit-23-535){ref-type="table-fn"}
  hsa-miR-181a   1             0.18[\*](#tfn1-medscimonit-23-535){ref-type="table-fn"}   0.37[Δ](#tfn2-medscimonit-23-535){ref-type="table-fn"}
  hsa-miR-210    1             0.15[\*](#tfn1-medscimonit-23-535){ref-type="table-fn"}   0.26[Δ](#tfn2-medscimonit-23-535){ref-type="table-fn"}
  hsa-miR-301a   1             0.26[\*](#tfn1-medscimonit-23-535){ref-type="table-fn"}   0.39[Δ](#tfn2-medscimonit-23-535){ref-type="table-fn"}

^1^*vs.* ^2^, *P*\<0.05;

^3^*vs.* ^2^, *P\>*0.05.
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